135 related articles for article (PubMed ID: 12189555)
1. Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA.
Maire F; Micard S; Hammel P; Voitot H; Lévy P; Cugnenc PH; Ruszniewski P; Puig PL
Br J Cancer; 2002 Aug; 87(5):551-4. PubMed ID: 12189555
[TBL] [Abstract][Full Text] [Related]
2. Serum HSP70: a novel biomarker for early detection of pancreatic cancer.
Dutta SK; Girotra M; Singla M; Dutta A; Otis Stephen F; Nair PP; Merchant NB
Pancreas; 2012 May; 41(4):530-4. PubMed ID: 22158074
[TBL] [Abstract][Full Text] [Related]
3. Artificial Intelligence Algorithm-Based Computerized Tomography Image Features Combined with Serum Tumor Markers for Diagnosis of Pancreatic Cancer.
Qiao Z; Ge J; He W; Xu X; He J
Comput Math Methods Med; 2022; 2022():8979404. PubMed ID: 35281945
[TBL] [Abstract][Full Text] [Related]
4. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
[TBL] [Abstract][Full Text] [Related]
5. β6-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma.
Lenggenhager D; Bengs S; Fritsch R; Hussung S; Busenhart P; Endhardt K; Töpfer A; The FO; Bütikofer S; Gubler C; Scharl M; Morell B
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00395. PubMed ID: 34388137
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of blood biomarker candidates for detection of pancreatic cancer.
Chen R; Crispin DA; Pan S; Hawley S; McIntosh MW; May D; Anton-Culver H; Ziogas A; Bronner MP; Brentnall TA
Pancreas; 2010 Oct; 39(7):981-8. PubMed ID: 20467349
[TBL] [Abstract][Full Text] [Related]
7. Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.
Dive C; Smith RA; Garner E; Ward T; George-Smith SS; Campbell F; Greenhalf W; Ghaneh P; Neoptolemos JP
Br J Cancer; 2010 Feb; 102(3):577-82. PubMed ID: 20051949
[TBL] [Abstract][Full Text] [Related]
8. Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9.
Jawad ZAR; Theodorou IG; Jiao LR; Xie F
Sci Rep; 2017 Oct; 7(1):14309. PubMed ID: 29085011
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer.
Takano S; Sogawa K; Yoshitomi H; Shida T; Mogushi K; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Ishihara T; Tanaka H; Yokosuka O; Nomura F; Miyazaki M
Br J Cancer; 2010 Jul; 103(2):223-31. PubMed ID: 20551957
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of SEREX-identified antigens and disease outcome in pancreatic cancer.
Heller A; Zörnig I; Müller T; Giorgadze K; Frei C; Giese T; Bergmann F; Schmidt J; Werner J; Buchler MW; Jaeger D; Giese NA
Cancer Immunol Immunother; 2010 Sep; 59(9):1389-400. PubMed ID: 20514540
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis.
Harlozinska-Szmyrka A; Strutynska-Karpinska M
Gut; 2004 Mar; 53(3):469-70. PubMed ID: 14960539
[No Abstract] [Full Text] [Related]
12. Extraordinarily high serum CA 19-9 in setting of pancreatic necrosis and underlying pancreatic adenocarcinoma: a case report.
McConnell A; Stoneman T; Hewlett S
J Surg Case Rep; 2023 Oct; 2023(10):rjad550. PubMed ID: 37846412
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of carbohydrate antigen 125 in chronic heart failure: Useful or futile?
Morillas H; Núñez J; Moliner P
Eur J Heart Fail; 2024 Apr; ():. PubMed ID: 38562007
[No Abstract] [Full Text] [Related]
14. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.
Gall TMH; Belete S; Khanderia E; Frampton AE; Jiao LR
Am J Pathol; 2019 Jan; 189(1):71-81. PubMed ID: 30558725
[TBL] [Abstract][Full Text] [Related]
15. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.
Cohen JD; Javed AA; Thoburn C; Wong F; Tie J; Gibbs P; Schmidt CM; Yip-Schneider MT; Allen PJ; Schattner M; Brand RE; Singhi AD; Petersen GM; Hong SM; Kim SC; Falconi M; Doglioni C; Weiss MJ; Ahuja N; He J; Makary MA; Maitra A; Hanash SM; Dal Molin M; Wang Y; Li L; Ptak J; Dobbyn L; Schaefer J; Silliman N; Popoli M; Goggins MG; Hruban RH; Wolfgang CL; Klein AP; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Lennon AM
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10202-10207. PubMed ID: 28874546
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.
Allenson K; Castillo J; San Lucas FA; Scelo G; Kim DU; Bernard V; Davis G; Kumar T; Katz M; Overman MJ; Foretova L; Fabianova E; Holcatova I; Janout V; Meric-Bernstam F; Gascoyne P; Wistuba I; Varadhachary G; Brennan P; Hanash S; Li D; Maitra A; Alvarez H
Ann Oncol; 2017 Apr; 28(4):741-747. PubMed ID: 28104621
[TBL] [Abstract][Full Text] [Related]
17. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.
Bestari MB; Joewono IR; Syam AF
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540782
[TBL] [Abstract][Full Text] [Related]
18. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review.
Ramírez-Maldonado E; López Gordo S; Major Branco RP; Pavel MC; Estalella L; Llàcer-Millán E; Guerrero MA; López-Gordo E; Memba R; Jorba R
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338919
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic tail cancer in the setting of pancreatitis with a review of the literature: A case report.
Rho S; Martin S; Nigogosyan Z; Kushnir V; Mintz AJ; Hu ZI
Clin Case Rep; 2023 Oct; 11(10):e8023. PubMed ID: 37830064
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
